Equity Report Outlook|24 carat financial services | 10 August 2017
Equity tips:-
Insecticides (India)
Q1 FY18 (YoY): PAT at Rs 30.5 Cr vs Rs 18 Cr (+69%). Revenue at Rs 345 Cr vs Rs 298 Cr (+16%).
Ajanta Pharma
Q1 FY18 (YoY): PAT at Rs 95 Cr vs Rs 119.5 Cr (-21%). Revenue at Rs 473 Cr vs Rs 476 Cr (-1%).
Bank of India
Q1 FY18 (YoY): PAT at Rs 88 Cr vs loss of Rs 741 Cr. Gross NPA at 13.05% vs 13.22%.
Closing Bell:
Gainers:
Hindalco (+2%),
NTPC, ONGC (+1%).
Losers:
Aurobindo (-6%),
Sun Pharma (-5%).
MARKET BUZZ:
Varun Beverages
enter into binding agreement to buy Pepsico India's manufacturing units at Cuttack, Bargarh and Bhopal.
Sun Pharma
stock slips over 5.5% after its subsidiary Taro Pharma posts weak Q1 results.
Union Bank
approves raising equity capital worth up to Rs 2,000 Cr.
JBF Industries
stock falls 17.5% after rating agencies downgraded the rating of the company on delays in servicing its debt obligations by JBF group.
Tata Chemicals
stock dips 3% on weak Q1 numbers and Haldia unit shutdown.
Bank of India
stock shines 4% on account of lower loan-loss provisions and narrowing of bad loan ratio in Q1 FY18. Stock spurts 6%.
Nifty Pharma Index
down 4%. Cadila (-9%), Divi's Lab (-7%), Aurobindo (-6%), Sun Pharma (-5.5%).
SRF
stock dips 6.5% on poor Q1 numbers; to set-up specialty chemicals facility in Dahej.
If you want to more information regarding the Stock tips,commodity tips, nifty tips missed call @ 9069102223 or fill form http://24cfin.com/free-trial
- NIFTY:-
| Equity tips |
- Nifty future is looking bearish on the charts .In today’s trading session Nifty traded with negative movement and closed with overall loss of 0.87%. Nifty has breached its important support mark of 10000 and sustaining below it. In upcoming trading sessions further down side movement can be seen in it and it can test down side levels of 9860 & 9820 if it breaches its next support level of 9900 while upside 10000 will act as a good resistance level.
| equity tips |
- Bank Nifty future is looking bearish on the charts .In today’s trading session Bank Nifty traded with negative movement and closed with overall loss of 1.05%. Bank Nifty has breached its support level of 24600 and sustaining below it. In upcoming trading sessions further down side movement can be seen in it and it can test down side levels of 24300 & 24200 if it breaches its next support level of 24400 while upside 24600 will act as a good resistance level.
- NIFTY & SENSEX
- Nifty closed at 9,908, down by 70 points while Sensex closed at 31,797, down by 216 points on Wednesday. The market witnessed lower closing for three consecutive trading sessions for the first time in six weeks.
- Hindalco was the top Nifty gainer closing at Rs 239.2 per share, up by 1.83% whereas Aurobindo Pharma was top Nifty loser ended at Rs 682 per share, down by Rs 44 per share or 6.08%. There were 324 advances, 1,322 declines and 296 unchanged stocks on NSE, reflecting strong negative sentiments floating in the market.
- In the broader markets, BSE Mid-cap index ended at 15,156 level, down by 256 points or 1.66% while BSE Small-cap index ended at 15,605 level, down by 298 points or 1.88%.
- Nifty Pharma index was the top loser among sectoral indices closing lower by 359 points at 8,766 level. Cadila Healthcare was the top loser on the index closing at Rs 480.9 per share, down by Rs 49 per share or 9.26%. Other pharma stocks including Divi’s Lab, Aurobindo Pharma, Sun Pharma and Glenmark ended lower by up to 7%.
- Realty stock, HDIL was the eye catcher of the day. The stock witnessed great volatility. It touched its fresh 52-week low of Rs 47 per share, down by nearly 17% in morning hour, however, in the second half of Wednesday’s trading session, the stock turned green to touch its intraday high of Rs 61.7 per share, up by 9.3%. It closed at Rs 57.2 per share.
- Result Update:
Q1 FY18 (YoY): ata Motors
- PAT at Rs 3,200 Cr vs Rs 2,260 Cr (+42%).
- Revenue at Rs 58,493 Cr vs Rs 65,004 Cr (-10%).
- EBITDA at Rs 5,595 Cr vs Rs 7,616 Cr (-27%).
- JLR profit before tax at £595 mn.
- One-time gain of Rs 3,609 Cr due to changes made in JLR pension plan
Mahanagar Gas
Q1 FY18 (YoY): PAT at Rs 124 Cr vs Rs 91.5 Cr (+36%). Revenue at Rs 583 Cr vs Rs
546.5 Cr (+7%).
NHPC
Q1 FY18 (YoY): PAT at Rs 863 Cr vs Rs 857.8 Cr (+1%). Revenue at Rs 2327.5 Cr vs
Rs 2197 Cr (+6%).
Insecticides (India)
Q1 FY18 (YoY): PAT at Rs 30.5 Cr vs Rs 18 Cr (+69%). Revenue at Rs 345 Cr vs Rs 298 Cr (+16%).
Ajanta Pharma
Q1 FY18 (YoY): PAT at Rs 95 Cr vs Rs 119.5 Cr (-21%). Revenue at Rs 473 Cr vs Rs 476 Cr (-1%).
Bank of India
Q1 FY18 (YoY): PAT at Rs 88 Cr vs loss of Rs 741 Cr. Gross NPA at 13.05% vs 13.22%.
Closing Bell:
Gainers:
Hindalco (+2%),
NTPC, ONGC (+1%).
Losers:
Aurobindo (-6%),
Sun Pharma (-5%).
MARKET BUZZ:
Varun Beverages
enter into binding agreement to buy Pepsico India's manufacturing units at Cuttack, Bargarh and Bhopal.
Sun Pharma
stock slips over 5.5% after its subsidiary Taro Pharma posts weak Q1 results.
Union Bank
approves raising equity capital worth up to Rs 2,000 Cr.
JBF Industries
stock falls 17.5% after rating agencies downgraded the rating of the company on delays in servicing its debt obligations by JBF group.
Tata Chemicals
stock dips 3% on weak Q1 numbers and Haldia unit shutdown.
Bank of India
stock shines 4% on account of lower loan-loss provisions and narrowing of bad loan ratio in Q1 FY18. Stock spurts 6%.
Nifty Pharma Index
down 4%. Cadila (-9%), Divi's Lab (-7%), Aurobindo (-6%), Sun Pharma (-5.5%).
SRF
stock dips 6.5% on poor Q1 numbers; to set-up specialty chemicals facility in Dahej.
If you want to more information regarding the Stock tips,commodity tips, nifty tips missed call @ 9069102223 or fill form http://24cfin.com/free-trial

Comments
Post a Comment